Edwards Lifesciences | EW

Stock Price
85.79
Daily Change
0.53%
Yearly
-11.02%
Q2 Forecast
82.87
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Abbott 103.76 -0.44 -0.42% -10.87%
AtriCure 47.08 0.15 0.32% 12.74%
Baxter International 41.65 0.32 0.77% -42.55%
Becton, Dickinson and Co. 253.96 2.17 0.86% -1.84%
Boston Scientific 51.40 -0.42 -0.81% 30.52%
Cooper Companies 353.55 -2.92 -0.82% 2.59%
Artivion 14.95 -0.34 -2.22% -17.08%
Dexcom 124.66 2.09 1.71% 68.28%
Edwards Lifesciences 85.79 0.45 0.53% -11.02%
Globus Medical 55.46 -0.32 -0.57% -10.40%
Hologic 79.04 -0.02 -0.03% 5.20%
Integra LifeSciences 39.64 0.70 1.80% -34.07%
ICU Medical 188.02 3.56 1.93% 5.62%
Inogen 10.01 -0.81 -7.49% -61.49%
Intuitive Surgical 317.49 5.31 1.70% 46.69%
J&J 158.39 1.42 0.90% -10.21%
Masimo 164.71 1.41 0.86% 17.16%
Medtronic 83.73 -0.03 -0.04% -12.32%
Merit Medical Systems 83.95 -0.40 -0.47% 36.50%
NuVasive 38.97 -0.45 -1.14% -24.65%
Insulet 284.07 3.04 1.08% 33.98%
Stryker 278.26 -0.05 -0.02% 21.96%
Teleflex 240.67 4.20 1.78% -15.20%
Tandem Diabetes Care 24.25 -0.52 -2.10% -61.50%
Zimmer Biomet Holdings 130.47 0.66 0.51% 10.19%

Indexes Price Day Year
US500 4271 -8.58 -0.20% 3.63%
US400 2479 -26.25 -1.05% -2.23%

Edwards Lifesciences

Edwards Lifesciences traded at $85.79 this Monday June 5th, increasing $0.45 or 0.53 percent since the previous trading session. Looking back, over the last four weeks, Edwards Lifesciences gained 3.63 percent. Over the last 12 months, its price fell by 11.02 percent. Looking ahead, we forecast Edwards Lifesciences to be priced at 82.87 by the end of this quarter and at 75.86 in one year, according to Trading Economics global macro models projections and analysts expectations.

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.